Home The Active Ingredient Matrix Beta-cryptoxanthin

Formulation Intelligence

Beta-cryptoxanthin

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Beta-cryptoxanthin.

Beta-cryptoxanthin is a provitamin A carotenoid and potent antioxidant that modulates osteoblast activity and suppresses osteoclastogenesis via the RANKL/RANK signaling pathway, primarily targeting bone density and respiratory health.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

5281235

Molecular Weight

552.9 g/mol

XLogP3 (Lipophilicity)

12.3

IUPAC Name

(1R)-3,5,5-trimethyl-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Vitamin D3 for synergistic enhancement of bone mineral density and calcium homeostasis.
  • Zinc for potentiation of osteoblastic differentiation and protein synthesis.

Biological Formulation Enhancers

  • Medium-chain triglycerides (MCTs) for micellar solubilization and enhanced lymphatic transport of lipophilic carotenoids.
  • Piperine for inhibition of glucuronidation and potential increase in systemic bioavailability.

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Beta-cryptoxanthin across standard consumer modalities.

💊 Standard Capsules

Beta-cryptoxanthin is highly susceptible to oxidative degradation and requires nitrogen flushing or the inclusion of antioxidants like mixed tocopherols within the lipid carrier to maintain potency.

🍬 Gummy & Pectin Formats

The high lipophilicity of beta-cryptoxanthin necessitates pre-emulsification to prevent phase separation and ensure uniform distribution within the hydrophilic pectin or gelatin matrix.

🔬 Thin-Film Oral Strips

The low water solubility and significant dosage requirements for clinical efficacy pose a challenge for thin-film loading capacity, often resulting in recrystallization and compromised film integrity.

For Brand Founders

Formulate with Beta-cryptoxanthin

Ready to launch a product featuring Beta-cryptoxanthin? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Beta-cryptoxanthin Bioavailability

Need absolute proof that your Beta-cryptoxanthin extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Beta-cryptoxanthin Degradation Testing

Is your Beta-cryptoxanthin payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation